GlassScriptPhysician profile
Chirag B Patel
NPI 1467727792
$13,657.50
in general payments reported to CMS, 2019-2025
8 companies · $70.69 in 2025
The $70.69 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $20.95 · 2021: $3,223 · 2022: $1,036 · 2023: $8,256 · 2024: $312 · 2025: $70.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Food and Beverage: $526 · Travel and Lodging: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Food and Beverage | $526.43 |
| Travel and Lodging | $312.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,075.30 | 2021-2023 | |
| Novocure INC. | $5,069.35 | 2019-2023 | Optune |
| Intuitive Surgical, INC. | $312.04 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $85.50 | 2022-2023 | Austedo |
| Mallinckrodt Hospital Products INC. | $37.45 | 2025 | Acthar |
| Csl Behring | $33.24 | 2025 | Hizentra, Privigen |
| Tg Therapeutics, INC. | $23.67 | 2023 | |
| Allergan, INC. | $20.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.